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Abstract
Background: OTUB1 is a member of OTUs (Ovarian-tumor-domain-containing proteases), a deubiquitinating enzymes
family (DUBs), which was shown as a proteasome-associated DUB to be involved in the proteins Ub-dependent degradation.
It has been reported that OTUB1 was expressed in kidney tissue. But its concrete cellular location and function in the kidney
remain unclear. Decorin (DCN) in mesangial cells (MC) is considered to be a potentially important factor for antagonizing
glomerulonephritides, and its degradation is mediated by ubiquitination. The aim of this study is to investigate the role of
OTUB1 expression in MC and its relationship with DCN during glomerulonephritis.
Methodology/Principal Findings: Using quantitative RT-PCR and Western blot, we demonstrated that OTUB1 mRNA and
protein were constitutively expressed in cultured rat MC and found to be upregulated by the stimulation of IL-1b or ATS.
OTUB1 overexpression was detected in the mesangial area of glomeruli in some immunocomplex mediated nephritides
such as IgA nephropathy, acute diffuse proliferative glomerulonephritis and lupus nephritis by immunohistochemistry. The
immunoprecipitation assay demonstrated that OTUB1 interacted with DCN. The overexpression of OTUB1 enhanced the
ubiquitination and degradation of DCN in MC.
Conclusion/Significance: These data showed the inflammatory injury could up-regulate OTUB1 expression in MC, which
might attribute the promoting effect of OTUB1 on glomerulonephritides to the decrease of DCN level.
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Introduction
Ovarian-tumor-domain-containing proteases (OTUs) are part
of the deubiquitinating enzymes (DUBs) family [1,2]. They have
been implicated to play an important role in mediating the
processes of proteins ubiquitination and degradation through
ubiquitin-proteasome pathway (UPP). DUBs are large groups of
cysteine proteases that are classified into six main families, such as
UBPs (ubiquitin-processing proteases), UCHs (ubiquitin C-termi-
nal hydrolases), ataxin-3/Josephin domains, OTUs (ovarian-
tumour-domain-containing proteases), pathogen-encoded ubiqui-
tin-processing proteases and JAMM (JAB1/MPN/MOV34 me-
talloenzyme) proteases [3]. DUBs can hydrolyze isopeptide bonds
between ubiquitin and folded proteins, remove the ubiquitin or
polyubiquitins from target proteins, and interfere the degradation
of substrates in the Ub-dependent pathway [4]. DUBs are
generally recognized as negative regulator to reverse the process
of ubiquitinization [3,5]. However, DUBs are also found recently
to be involved in a multiprotein complex of proteasom to facilitate
substrates degradation in ER stress. During the proteolysis by
proteasome, the removal of the Ub chain from the substrate by
proteasome-associated DUBs such as OTUB1 is a key to allow the
passage of the unfolded polypeptide through a narrow constriction
into the proteolytic chamber of the proteasome core particle,
where proteolysis ensues [6,7].
One of the most recently recognized DUBs is the OTUs. This
family mainly comprises a group of putative cysteine proteases
including OTUB1, OTUB2, A20 and yeast OTU1 [2]. All of
them have an OTU domain of 130 amino acids that is highly
conserved from yeast to mammals [1]. The OTU family is a
matter of considerable interest to us due to its conserved sequences
in viruses, bacteria, plants, yeast, and humans, and its role in
immunity and inflammation [8]. OTUB1 was the first member of
OTU family to be confirmed for its deubiquitinating properties. It
is located at chromosomal position 11q13.1, and is ubiquitously
expressed in human tissues [9]. A structural analysis of OTUB1
shows differences in accessibility to the active site and in surface
properties of the substrate-binding regions that may reflect
functional diversity in regulatory mechanisms and substrate
specificity [2]. Recently, study has shown that YOD1, which is
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associated DUB to be involved in the ER-associated degradation
(ERAD) pathway, which is related to the metabolism of numerous
glycoprotein [6,10,11]. Therefore, OTUB1 is thought to play an
important role in many physiological and pathological processes of
human being. The OTUB1 gene product is identified to be
involved in the control of cell division and differentiation of the
cystoblast into an oocyte and nurse cells [12,13]. Although widely
expressed, OTUB1 was specifically implicated in mediating
lymphocyte antigen responsiveness through affecting the stability
of the lymphocyte-specific E3 ligase GRAIL (gene related to
anergy in lymphocytes) in CD4+ T-lymphocytes [14]. Moreover,
OTUB1 was also found in Lewy bodies of the brain on mass
spectrometry, and may be involved in the pathogenesis of
neurodegenerative disorders [15].
OTUB1 expressing in kidney tissue has been detected by RT-
PCR and Western blot [16]. However, its concrete cellular
location and function in the kidney are unknown. There are also
no relative reports about its relationship with kidney diseases.
Decorin (DCN) is a small proteoglycan composed of a core
protein and a glycosaminoglycan chain. It has been shown that
DCN has a variety of functions and may interfere the binding of
TGF-b to its receptor complex [17]. Forced expression of DCN in
human mesangial cells (MC) inhibit the expression of TGF-b1 and
Collagen IV [18–20]. It plays a critical role in the reduction of
ECM deposition in mesangium during glomerulonephritis,
inhibition of mesangial cell (MC) proliferation, and impediment
of glomerulosclerosis development [21].Therefore, DCN is
considered to be a potentially important factor for antagonizing
glomerulonephritides.
Recently, the investigation of metabolism and regulation of
DCN has been expanded. Our prior report showed that
intracellular DCN was degraded by the UPP in MC [22].
Furthermore, on mass spectrometric analysis of immunoprecipi-
tation gels using DCN-antibody, we found that OTUB1was highly
expressed in MC (data not shown), which suggested a possible
interaction of OTUB1 with DCN. We thus speculated that the
deubiquitinating enzyme OTUB1 may mediate the process of
DCN degradation in MC. To understand the mechanism of this
event would help to elucidate the role of OTUB1 expression and
its relationship with DCN during glomerulonephritis.
In this study, we examined OTUB1 expression in rat MC with or
without stimulation of inflammatory factors and the ectopic
expression of OTUB1 in biopsy tissues of human kidney with some
common glomerulonephritides. Further immunoprecipitation stud-
ies were performed to investigate the interaction between OTUB1
and DCN in MC. The aim of our study was to test our hypothesis
that OTUB1 is implicated in pathogenesis of glomerulonephritides.
Results
1. The expression of OTUB1 in cultured MC
In cultured MC, OTUB1 mRNA was found with an amplified
fragment of 850 bp by using RT-PCR (Figure 1a), and OTUB1
protein expression was confirmed by Western blot with a
molecular weight of 36 kD (Figure 1b). Immunofluorescence
detection of OTUB1 was also performed with positive fluorescent
signals in the cytoplasm and nuclei of MC compared to the
corresponding control (Figure 1c).
2. Upregulation of OTUB1 and DCN mRNA in MC were
mediated by IL-1b and ATS
Quantitative real time PCR showed that OTUB1 mRNA was
markedly upregulated in rat MC after administrating of IL-1b for
3, 6, 12 and 24 hours. There was a statistically significant
difference between the administrating and normal control groups
(p,0.05). To observe the relationship between OTUB1 and DCN
in MC, DCN mRNA was also tested synchronously and found to
be significantly upregulated in rat MC after exposure to IL-1b for
3, 6, 12 and 24 hours, compared with controls (p,0.05; Figure 2a).
After treatment of MC with ATS for 3, 6, 12 and 24 hours,
both OTUB1 and DCN mRNA were significantly increased in
administrating groups versus normal groups (p,0.05; Figure 2b),
besides the group of OTUB1 in ATS treating for 3 h. This
suggested that the IL-1b and ATS may upregulate the expression
of OTUB1 in MC.
3. The protein expression of OTUB1 and DCN in MC were
mediated by IL-1b and ATS
We continued to detect the protein level of OTUB1 and DCN in
cultured MC after treatment with IL-1b and ATS. Western blot
analysis showed that OTUB1 expression increased in cells exposed
to IL-1b at 3, 6, 12, and 24 hours (p,0.05, Figure 3a), which was
consistent with the expression of their mRNA. However, increased
expression of DCN induced by IL-1b was found at 3 and 6 hours,
significantly different from that in cells of health controls (p,0.05),
then its expression decreased quickly at IL-1b 12 and 24 hours.
There was nosignificant difference ofDCNexpression at cellsofIL-
1b 24 h compared with health control cells (p.0.05) (Figure 3a).
The same pattern occurred in MC treated with ATS. OTUB1
expression was significantly higher in ATS treated cells at 6, 12,
and 24 hours, while DCN was higher at 3 and 6 hours compared
to cells of health controls (p,0.05 ), and again declined in 12 and
24 hours (Figure 3b). These results demonstrated that IL-1b or
ATS could upregulate the protein level of OTUB1 in MC. In
contrast, both factors could downregulate the protein level of
DCN after a transient response of up-expression in the early
stages. It suggested that the mechanism of regulation for the two
proteins in MC might be different post-transcriptionally.
4. Upregulation of OTUB1 in MC with
glomerulonephritides
55 samples were acquired from kidney needle biopsy, including 8
cases from healthy kidney tissue (distant from kidney tumor), 8
minimal change disease (MCD), 7 membranous glomerulonephrit-
ides (MGN), 10 mesangial proliferative type of IgA nephropathy
(IgAN), 12 acute diffuse proliferative glomerulonephritides (APGN),
and 10 lupus nephritis, subtype IV (LN-IV). Immune-reaction
staining demonstrated that OTUB1 expression was diversely
present in nephropathy samples, but with few positive cells in the
normal glomeruli. The degree of OTUB1 expression in the
mesangial region of the glomeruli differed among the various types
of glomerulonephritides. The average optical density in the
glomerulus was 0.004506 in MCD, and 0.004028 in MGN; both
were not significant different from that in normal kidney tissue
(0.002096) (p.0.05). In contrast, the average optical density was
0.03412 in IgAN, 0.065412 of the APGNglomerulus, and 0.088363
of the LN-IV glomerulus, all of which were significantly higher than
that in normal kidney tissue (p,0.01) (Table 1). OTUB1
immunostaining was localized mainly in the mesangial area, in
which the brown granules were distributed diffusely, which
consisted with the morphological features of dendritic MC.
Moreover, some of the parietal epithelial cells of Bowman’s capsule,
crescentand partofthetubularepitheliumwereOTUB1positive.It
was demonstrated that OTUB1 expression was upregulated in MC
of diseased glomeruli, which correlated with the type and intensity
of pathological changes in various glomerulonephritides (Figure 4).
Expression of OTUB1 in Mesangial Cells
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DCN in MC
To study the role of OTUB1 in regulating the level of DCN in
MC, we constructed eukaryotic expression plasmid pIRES2-
EGFP-OTUB1-myc and stable transfected vector into cultured rat
MC by cationic lipid mediator. The RT-PCR and Western blot
results showed that the positive cell clones markedly overexpressed
OTUB1 mRNA and protein, including myc tag protein
(Figure 5a–b). Meanwhile, the DCN protein levels were also
obviously lower in OTUB1 transfected MC than that in normal
control cells (Figures 5b). The data indicated that OTUB1
overexpression could induce a decrease of the DCN level in rat
MC.
6. OTUB1 and DCN immunoprecipitation with increasing
the ubiquitination of DCN in MC
To further study the link between OTUB1 and DCN in MC,
immunoprecipitation assays were performed with an anti-OTUB1
antibody and blotted with anti-OTUB1, anti-myc, and anti-DCN
antibodies in OTUB1 transfected MC. As shown in Figure 6a (top
bands), the OTUB1 and myc bands were seen in MC. While the
nonspecific IgG was negative, the cellular total protein was the
positive control. Reprobing the same membrane with anti-DCN
antibody confirmed the specificity of OTUB1 combining with
DCN (Figure 6A, lowest band). Conversely, in reciprocal
immunoprecipitation with anti-DCN, the OTUB1 was also
detected in depositing protein linking with DCN (Figure 6b).
Then, the ubiquitination of DCN was determined by anti-
ubiquitin antibody after DCN immunoprecipitation. As shown
in Figure 6c, the level of ubiquitinated DCN were significantly
higher in OTUB1 transfected MC than that in vacant vector
transfected MC. These results indicate that OTUB1 does interact
with DCN and promote the process of DCN ubiquitination and
degradation.
Discussion
Here we report, for the first time, OTUB1 expression in
cultured rat MC with or without inflammatory factor stimulation
Figure 1. The expression of OTUB1 in MC. (a) RT-PCR analysis of OTUB1 performed on total DNA extracted from MC. (b) Western blot analysis of
OTUB1 in MC using anti-OTUB1 antibodies. (c) Immunofluorescence staining of OTUB1 in MC using anti-OTUB1 antibody(A1), Hoechst 33258 staining
(A2), isotype control antibody staining (B1) and Hoechst 33258 staining (B2).
doi:10.1371/journal.pone.0029654.g001
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human MC of glomeruli from various nephritides by using
immunohistochemistry. Balakirev demonstrated that OTUB1
expression was relatively higher in the kidney [16]. It remains
uncertain whether OTUB1 is expressed in glomeruli. In our study,
constitutive expression of OTUB1 was shown, and upregulation of
OTUB1 mRNA and protein level induced by IL-1b and ATS
were observed in cultured MC. ATS can interact with antigens on
the cell membranes of MC to form immune complexes, which
subsequently activate complement in fresh serum to assemble the
sublytic C5b-9, leading to immune injury of cells in vitro [23,24].
Therefore, it was confirmed that cytokines and immune
stimulation could promote OTUB1 upregulation in MC. Consist-
ing with the cell test, OTUB1 overexpression was also observed in
mesangial area in some immunocomplex-mediated nephritides
such as IgAN, APGN and LN. These data suggested that OTUB1
upregulation may relate to the pathological changes of glomeru-
lonephritides.
Recently, the OTU family has attracted attention for its role
in innate immunity and inflammation of cells [8,14,25,26]. The
OTU Characterized by the presence of ovarian tumor domain-
containing sequences acts as general deubiquitinases. It can
hydrolyze ubiquitin and ISG15 from cellular target proteins,
antagonize the antiviral effects of ISG15, which enhance the
susceptibility to Sindbis virus infection in vivo [27]. A20 (also
known as tumor necrosis factor alpha-induced protein 3),
another member of OTU family [28], is a unique protein that
exerts both NFk-B inhibitory and anti-apoptotic activities, and is
now recognized as a key regulator in inflammation and
immunity [8,26,29]. Mice deficient for A20 are hypersensitive
to TNF and die prematurely due to severe multi-organs
inflammation and cachexia [30]. Recent genetic studies demon-
strate a clear association between several mutations in the
human A20 locus and immunopathologies such as Crohn’s
disease, rheumatoid arthritis, systemic lupus erythematosus,
psoriasis, and type 1 diabetes [31]. However, the mechanism
of OTUs mediation in these diseases has still not been fully
elucidated.
The pathogenesis of many primary and secondary glomerulo-
nephritides is also related to disorders of immune and inflamma-
tory response. Here we have found that OTUB1 ectopic
expression was related to MC injury and pathological changes of
glomerulonephritides. Therefore, we speculated that OTUB1 may
play an important role in the development of glomeruli diseases. In
this work, we not only confirmed the overexpression of OTUB1 in
diseased glomeruli, but also demonstrated that OTUB1 could
interact with DCN and promote DCN degradation. Since DCN is
an important antagonizing factor for glomeruli inflammation, it is
suggestion that OTUB1 may be another novel regulator involved
in the pathogenesis of glomerulonephritis.
Figure 2. OTUB1 and DCN mRNA were upregulated in MC stimulated with IL-1band ATS. (a) MC were treated with IL-1b10 ng/mL for 3 h,
6 h, 12 h and 24 h. (b) MC were treated with ATS 30 mL/mL for 3 h, 6 h, 12 h and 24 h respectively. mRNA levels of OTUB1 and DCN in MC were
analyzed by quantitative real-time PCR. Besides the group of OTUB1 in ATS treating for 3 h, both OTUB1 mRNA and DCN mRNA significantly
increased in all groups treated with IL-1b or ATS compared with normal group (*P,0.05, **P,0.01). Data are presented as mean6standard error (SE)
from at least three individual experiments carried out in duplicate.
doi:10.1371/journal.pone.0029654.g002
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regulated via the UPP for its degradation [22]. Here we further
demonstrated that OTUB1 overexpression induced by gene
transfection or by inflammatory stimulation could increase the
DCN ubiquitination and proteolysis in MC. The Schlieker’ lab
reported that another OTUB1-like protein YOD1 was a
proteasom-associated deubiquitinating processing factor in the
context of protein dislocation from the ER and degradated by
proteasomal proteolysis [6]. YOD1 is a constituent of a p97
complex for proteasome and it displays a strong ability to
deconjugate K48 linked Ub chains [9,28]. Ubiquitination is a
highly dynamic process carefully controlled by opposing Ub-
conjugating and deconjugating activities. In the case of the 26S
proteasome, deubiquitination is needed to remove the impediment
of attached Ub chains to allow the substrates get into the
proteolytic core particle. The otubain core domain of YOD1 is
necessary and sufficient for catalytic activity hydrolyzed K48-
linked poly- and di-Ub chains degradation of truncated substrate.
A dominant negative YOD1 variant stalled the proteolysis and
caused accumulation of ubiquitinated substrates [6]. So it
coincides with the fact that OTUB1 may serve as proteasome-
associated DUB to exert important function for a deubiquitinating
activity in the process of DCN degradation.
DCN can neutralize TGF-b1 bioactivity and inhibit the
development of glomerulonephritis and glomerulosclerosis
[32,33]. DCN administration has been advocated as a potential
antagonist against nephropathies because of the relative deficiency
of DCN and relative excess of TGF-b1 existing in glomerulone-
phritis [18,19]. Deficiency of DCN has been shown to enhance
progressive nephropathy in diabetic mice [32]. Some reports
showed that DCN expression increased in rat diabetic kidneys and
in glycogen-stimulated cultured MC, suggesting a possible
compensatory response to antagonize local TGF-b1 activity
Figure 3. OTUB1 and DCN expression mediated by IL-1b and ATS. (a) MC were treated with IL-1b 10 ng/mL for 3 h, 6 h, 12 h, 24 h,
respectively. Western blot analysis showed that OTUB1 expression increased with IL-1b at 3 h, 6 h, 12 h and 24 h, while the increased DCN expression
induced by IL-1b was found at 3 h and 6 h, which were significantly higher than that of normal controls. The expression of DCN then decreased
quickly at 12 h and 24 h. (b) MC were treated with ATS 30 mL/mL for 3 h, 6 h, 12 h and 24 h. OTUB1 expression was significantly higher in ATS treated
cells at 6 h, 12 h and 24 h, while DCN expression markedly increased at ATS 3 h and 6 h compared to normal controls. However, the DCN expression
declined again in 12 h and 24 h. (%) OTUB1/b-actin; (& )DCN/b-actin. (*P,0.05; **P,0.01). Data are presented as mean6standard error (SE) from at
least three individual experiments carried out in duplicate.
doi:10.1371/journal.pone.0029654.g003
Table 1. Quantitative analysis of OTUB1 immunoreactivity in
glomerulonephritides.







Immune staining of OTUB1 was quantitatively assessed on the mean density
(ratio of integrated optical density (IOD) to area of interest (AOI) per glomerulus
in normal kidney tissue and some nephropathy tissues. The expression of
OTUB1 was statistically significantly higher in IgA nephropathy, acute diffuse
proliferative glomerulonephritides and lupus nephritis than that in normal
kidney tissue (**P,0.01).
doi:10.1371/journal.pone.0029654.t001
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interstitial fibrosis in renal diseases [34,35]. Therefore, the
question remains: what is the change of DCN during the
development of chronic glomeruli diseases? In some glomerulo-
nephritides and severe diabetic glomerulosclerosis, increased DCN
concentration was found in the urine. Failure to detect increased
glomerular proteoglycan quantity during the development of
nephropathy could be partly explained by assuming that they are
Figure 5. Overexpression of OTUB1 downregulated the expression of DCN in MC. (a) mRNA expression of OTUB1 in MC after OTUB1 gene
transfection was assessed by RT-PCR. Lane 2, 5, 8 are normal mesangial cells (MC) as control, Lane 3, 6, 9 are pIRES2-EGFP-OTUB1-myc stable
transfected MC (MC/OTUB1), Lane 4, 7, 10 are vacant vector pIRES2-EGFP transfected MC (MC/pIRES2). The mRNA expression of OTUB1 increased in
lane 9. (b) Protein expression of OTUB1 and DCN were assessed by Western blot. Lane 1 is normal mesangial cells (MC) as negative control, Lane 2 is
pIRES2-EGFP-OTUB1-myc stable transfected MC (MC/OTUB1), Lane 3 is vacant vector pIRES2-EGFP transfected MC (MC/pIRES2). Overexpression of
OTUB1 was seen in lane 2 with myc labeling positive. Meanwhile, the DCN expression significantly decreased after OTUB1 gene transfection in lane 2.
(%) OTUB1/b-actin; (& )DCN/b-actin. (*P,0.05; **P,0.01). Data are presented from at least three individual experiments carried out in duplicate.
doi:10.1371/journal.pone.0029654.g005
Figure 4. OTUB1 expression in glomerular during some golmerulonephritides was detected by immunohistochemistry. (a) Normal
glomerulus, there is few positive staining in golmerulus; (b) minimal change disease; (c) membranous glomerulonephritis, there is minor positive in
the mesangium at (b) and (c); (d) IgA nephropathy, moderate positive in the mesangium; (e) acute proliferative glomerulonephritis; (f) lupus nephritis.
The increased positive staining was seen in mesangium at (d), (e) and (f). In addition, the tubular epithelial cells are partially diaminobenzidine
positive. Hematoxylin is used as the nuclear counterstain. (ABC immunochemistry, 6100).
doi:10.1371/journal.pone.0029654.g004
Expression of OTUB1 in Mesangial Cells
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29654secreted into the mesangial matrix, partly to form complexes with
TGF-b1 and partly to be cleared via the vasculature or the urinary
tract [36,37]. Furthermore, it was interesting to note in our work
that DCN was transiently upregulated in cultured MC under IL-1
or ATS stimulation, and then returned quickly to baseline
(Figure 3), while DCN mRNA was still kept at a high level. It
may imply that the loss of DCN was caused by post-transcriptional
proteolysis. These phenomena revealed that a part of the
intracellular DCN protein might be quickly degraded during
MC injury. It was further validated by the experiment that
overexpression of OTUB1 increased the ubiquitination of DCN in
MC. We might thus attribute the promoting effect of OTUB1 on
glomerulinephritides to the decrease of DCN level.
In summary, we demonstrated that OTUB1 was expressed in
MC in vitro and in vivo. OTUB1 expression was upregulated in
MC after inflammatory stimulation. There was a relationship
between the OTUB1 upregulation and pathological changes of
glomerulonephritides. OTUB1 could interact with DCN in MC.
The overexpression of OTUB1 promoted DCN ubiquitination
and degradation, which may contribute to the pathogenesis of
glomerulonephritides. Thus, OTUB1 revealed to be a possible
novel regulator during glomerulonephritides, which would facil-
itate degradation of DCN and enhance the vicious circle
characterized by increased TGF-b1 production and matrix
deposition in developing glomerulosclerosis. Our work also
presented an example of OTUB1 as a proteasome-associated
DUB to mediate proteasomal proteolysis.
Materials and Methods
Antibodies and reagents
Mouse anti-DCN was purchased from R&D Systems (Minne-
apolis, MN, USA). Rabbit anti-OTUB1, mouse anti-myc
monoclonal antibody, mouse anti-b-actin monoclonal antibody,
and IL-1b were purchased from Sigma-Aldrich (St. Louis, MO,
USA). mouse anti-ubiquitin monoclonal antibody and Protein G
PLUS-Agarose was purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). Plasmid Midiprep Kit, Opti-MEM,
Lipofectamine 2000, and Trizol reagent were purchased from
Invitrogen (Carlsbad, CA, USA). The Super Signal West Pico
stable peroxide solution enhanced chemiluminescence (ECL)
system and the bicinchoninic acid (BCA) Protein Assay Reagent
Kit were obtained from Pierce Biotechnology (Rockford, IL,
USA). All other reagents were obtained from Sangon Biological
Engineering Technology & Service Co. Ltd. (Shanghai, China).
Cell culture and treatment
MC were prepared from the cortex of male Sprague–Dawley
rat kidneys [38]. The cells were utilized between passages 6 and 10
and maintained in RPMI 1640 medium supplemented with 10%
newborn bovine serum (NBS) at 37uC in a humidified atmosphere
containing 5% CO2/95% air. MC were treated with different
reagents containing 10 ng/mL of recombinant rat IL-1b or 30 ml/
ml of rabbit ATS (anti-Thy1 serum) for 3, 6, 12, and 24 hours,
respectively. ATS was made in our lab as described in a prior
paper, which could cross-react with antigens on the cell membrane
of the MC in vitro [39].
Total RNA extraction and quantitative real-time RT-PCR
analysis
Total RNA was extracted from the lysates of rat MC using
Trizol reagent. Reverse transcription (RT) was carried out using a
PrimeScript RT reagent Kit at 37uC for 15 minutes and 85uC for
5 seconds. Real time quantitative RT-PCR was performed using a
SYBR Premix Ex Taq
TM Kit, in a total reaction volume of 20 ml
containing 10 ml of SYBR Green RT-PCR master mix, 2 mlo f
cDNA template and 0.4 mM of each target-specific primer
designed to amplify a part of each gene. After PCR, a melting
curve analysis was performed to demonstrate the specificity of
each PCR product as a single peak. The relative amounts of
OTUB1, DCN and GAPDH mRNA were calculated by
comparison with standard curves [40]. Changes in the mRNA
expression level were calculated following normalization with
GAPDH. The sequences of OTUB1 used were: sense: 59-
GCGACCACATCCACATCA-39, anti-sense: 59-TAGGACCA-
TTTACAACCACA GA-39. The sequences of DCN used were:
sense: 59-TGGCTAAGTTGGGATTGA-39, anti-sense: 59-CTG-
AAGGTGGATGGCTGT-39. The sequences of GAPDH used
were: sense: 59-AACGGATTTGGTCGTATTG-39, anti-sense:
59-GGAAGA TGGTGATGGGATT-39. The sizes of the ampli-
Figure 6. OTUB1 interaction with DCN in MC concomitant with increase of DCN ubiquitination. (a) MC was stable transfected with
pIRES2-EGFP-OTUB1-myc. Then we performed IP with OTUB1 antibody and analyzed by SDS-PAGE using antibodies against the OTUB1, myc and
DCN. (b) Reciprocal IP with anti-DCN antibody was analyzed using OTUB1 antibody. Lysate from MC (input) was used as a positive control, isotype
matched nonspecific IgG as negative control. Lane 2(M) represents marker. (c) Cell lysates were subjected to immunoprecipitation with anti-DCN
antibody followed by immunoblotting with an anti-ubiquitin (Ub) antibody. Lane 1 is normal mesangial cells (MC), cell lysates were analyzed by
immunoblotting. Lane 2 is vacant vector pIRES2-EGFP transfected MC (MC/pIRES2) as control, Lane 3 is pIRES2-EGFP-OTUB1-myc transfected MC (MC/
OTUB1), overexpression of Ub was seen in lane 3.
doi:10.1371/journal.pone.0029654.g006
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DCN, and GAPDH, respectively. All samples were run three
times. RT-PCR: RNA Extraction and reverse transcription are the
same as above. The conditions for PCR were hot-start (95uC) for
2 min, followed by 30 cycles of amplification (denaturation at
95uC for 30 s, annealing at 58uC, 55uC and 56uC for OTUB1, b-
actin and DCN for 30 s, respectively and extension at 72uC for
30 s). The final extension was at 72uC for 7 min. The sequences of
OTUB1 used were: sense: 59- GCCCTCGAGATGGCGGCG-
GAGGAACCTC-39, anti-sense: 59- GCGGATCCTCACA-
GATCCTCTTCTGAGATGAGTTTTTGTTCTTTGTAG-39;
and the sequences of b-actin used were: sense: 59- AGGATGCA-
GAAGGAGATTACTGCC-39, anti-sense: 59- AAAACGCAG-
CTCAGTAACAGTGC-39. The sequences of DCN used were:
sense: 59-TGGCAGTCTGGCTAATGT-39, anti-sense: 59- ACT-
CACGGCAGTGTAGGA -39. The sizes of the amplified frag-
ments were 850, 248 and 199 base pair for OTUB1, b-actin, and
DCN respectively. Final PCR products were electrophoresed in a
1% agarose gel.
Protein isolation and Western blot analysis
Cell pellets was lysed in cold cell lysis buffer (pH 7.4) (50 mM
Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10%
glycerol, 0.2 mg/mL NaN3, 1 mg/mL pepstatin A, 1 mg/mL
aprotinin, 1 mg/mL leupeptin, and 1 mmol/L phenylmethylsul-
fonyl fluoride) for 30 minutes on ice. Then, 60 mg of protein was
loaded with 56SDS loading buffer and resolved by (10%) SDS-
polyacrylamide gel electrophoresis (PAGE), then transferred onto
a PVDF membrane (Millipore, Eschborn, Germany). The
membrane was blocked with 5% non-fat milk solution in room
temperature for 1 hour, then immunoblotted with OTUB1
polyclonal antibody (1:50 dilution), DCN monoclonal antibody
(1:1,000 dilution), Ubiquitin monoclonal antibody (1:1000 dilution
) and b-actin monoclonal antibody (1:1,000 dilution). Detection by
enzyme-linked chemiluminescence was performed according to
the manufacturer’s protocol (ECL; Pierce Biotechnology). The
housekeeping protein b-actin was used as a control. Results were
analyzed quantitatively using Gelpro32 (Media Cybernetics,
Shanghai, China). Each experiment was repeated at least three
times.
Immunoprecipitation
Precleared cell lysates (1 mg total protein) were immunoprecip-
itated with 1 mg of antibodies against either OTUB1 or DCN plus
30 mL of Protein G Sepharose beads, after adjusting the volumes
to 0.5 ml with NET buffer (50 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 0.1% Nonidet P (NP)-40, 1 mM ethylene diamine tetra-
acetic acid, 0.25% gelatin, 0.02% sodium azide, 1 mM PMSF,
and 1% aprotinin), and incubated overnight at 4uC. The beads
were centrifuged at 2000 G for 5 minutes at 4uC and washed
three times with 500 mL NET buffer, and once with PBS.
Immunoprecipitated proteins were eluted with 56SDS loading
buffer and resolved by standard SDS–PAGE. The following steps
were the same as for Western blotting.
Immunofluorescence
For immunofluorescence experiments, cells were seeded onto
the glass coverslip and fixed in paraformaldehyde. After a brief
washing with PBS buffer, the fixed cells were incubated with anti-
OTUB1 (1:100) antibody and nonspecific isotype control antibody
(1:100) for 1 hour at 37uC, followed by incubation with TRITC-
conjugated secondary antibody at 37uC for 45 minutes. Photos
were taken by fluorescence microscope.
Immunohistochemistry
Renal needle biopsies were collected at the nephrosis
laboratory, Department of Pathology, Shanghai Medical College,
Fudan University, in accordance with our institutional ethics
guidelines. Paraffin sections (4 mm) of biopsy tissue were
deparaffinized, endogenous peroxidase was quenched using 3%
H2O2, and antigen retrieval was performed by microwave in a
10 mmol/L citrate buffer, pH 6.1. Non-specific binding was
blocked using 5% normal sheep serum for 30 minutes at 37uC.
Sections were then incubated with a rabbit polyclonal anti-
OTUB1 antibody (1:100) at 37uC for 1 hour, then overnight at
4uC. Immobilized antibodies were detected by biotinylated
secondary antibody (ABC assay Kit; Vector Laboratories, Orton
Southgate, UK). Diaminobenzidine (DAB) was used as the
chromogen substrate and hematoxylin stain was the nuclear
counterstain. The primary antibody was replaced by PBS or
normal rabbit serum (1:100) as negative control.
Immunohistochemistry of the OTUB1 staining was assessed
using Image-Pro Plus 6.0 software (Media Cybernetics). At least
five glomeruli were selected from each section under microsco-
py. the positive area inside a glomerular was calculated with the
total OTUB1-positive area in global capillary tufts divided by
the whole glomerulus area. The mean absorbance of the
OTUB1 position per glomerulus was calculated for each
nephritis group. The absorbance of OTUB1 position was
defined as the integrated optical density (IOD) in the global
capillary tufts divided by the whole glomerulus area (area of
interest, AOI).
OTUB1 Stable transfection on rat MC
The pIRES2-EGFP-OTUB1-myc plasmid was amplified in E.
coli DH5.a and the authenticity was verified by sequencing. MC
(1610
6 cells) was seeded in six well plates with 70–80%
confluence. The cells were washed twice with PBS, then three
times with Opti-MEM before transfection. The plasmid DNA
(10 mg) of pIRES2-EGFP-OTUB1-myc and 10 mLo fL i p o f e c t a -
mine 2000 were incubated in 250 mL Opti-MEM for 5 minutes
at room temperature and then mixed for another 30 minutes at
room temperature. The 500 mL complex was added into the
culture dishes and the cells were incubated at 37uCf o r
6.5 hours, followed by the addition of 2 ml 10% fetal calf
serum/DMEM medium. After 3 days, stable clones were
selected in the presence of 0.4 mg/ml Geneticin (G-418, Sigma).
After 3 weeks, positive clones were selected by both Western
blotting and RT-PCR analysis after culture expansion. Control
cells were transfected with an empty vector pIRES2-EGFP
alone.
Statistical analysis
Statistical analysis was performed using SPSS software (Chi-
cago, IL,USA). The Student’s t-test was used for analysis of paired
data in the in vitro assays. The one-way ANOVA test was used to
assess the differences among multiple groups in the in vivo assays. A
p-value of less than or equal to 0.05 was regarded as statistically
significant. Data were presented as the mean 6 standard deviation
(SD) of triplicate experiments. The density of the bands on the
Western blots was quantified by densitometry and analyzed by a
Gel-Pro Analyzer from Media Cybernetics (Silver Spring, MD,
USA).
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